Decreased Tumorigenicity In Vivo When Transforming Growth Factor β Treatment Causes Cancer Cell Senescence

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 4, 2003, Pages 815-821

  Katakura, Yoshinori ^a   Nakata, Eriko ^a   Tabira, Yukiko ^a   Miura, Takumi ^a   Teruya, Kiichiro ^a   Tsuchiya, Toshie ^b   Shirahata, Sanetaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Cellular senescence; Telomerase; Telomere; Transforming growth factor 1 (TGF ); Tumor suppression

Indexed keywords

MUS MUSCULUS;

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; INTERLEUKIN 6; SMAD PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL AGING; CELL CULTURE; CELL DIVISION; CONTACT INHIBITION; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; MOUSE; NEOPLASM; NUDE MOUSE; PATHOLOGY; SECRETION; TELOMERE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL AGING; CELL DIVISION; CONTACT INHIBITION; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-6; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; SMAD PROTEINS; TELOMERE; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0041318886     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.67.815     Document Type: Article

References (23)

1. Campisi, J., Cancer, aging and cellular senescence. In Vivo, 14, 183-188 (2000).
2. Smith, J. R., and Pereira-Smith, O. M., Replicative senescence: implications for in vivo aging and tumor suppression. Science, 273, 63-67 (1996).
3. Young, J. I., and Smith, J. R., DNA methyltran-sferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J. Biol. Chem., 276, 19610-19616 (2001).
4. Dimri, G. P., Itahana, K., Acosta, M., and Campisi, J., Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol., 20, 273-285 (2000).
5. INK4a. Cell, 88, 593-602 (1997).
6. Zhu, J., Woods, D., McMahon, M., and Bishop, J. M., Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev., 12, 2997-3007 (1998).
7. Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., and Lowe, S. W., Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev., 12, 3008-3019 (1998).
8. Lundberg, A. S., Hahn, W. C., Gupta, P., and Weinberg, R. A., Genes involved in senescence and immortalization. Curr. Opin. Cell. Biol., 12, 705-709 (2000).
9. Bringold, F., and Serrano, M., Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol., 35, 317-329 (2000).
10. Ghebranious, N., and Donehower, L. A., Mouse models in tumor suppression. Oncogene, 17, 3385-3400 (1998).
11. Boulanger, C. A., and Smith, G. H., Reducing mammary cancer risk through premature stem cell senescence. Oncogene, 20, 2264-2272 (2001).
12. Katakura, Y., Nakata, E., Miura, T., and Shirahata, S., Transforming growth factor b triggers two independent-senescence programs in cancer cells. Biochem. Biophys. Res. Commun., 255, 110-115 (1999).
13. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R., Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959 (1997).
14. Katakura, Y., Yamamoto, K., Miyake, O., Yasuda, T., Uehara, N., Nakata, E., Kawamoto, S., and Shirahata, S., Bidirectional regulation of telomerase activity in a subline derived from human lung adenocarcinoma. Biochem. Biophys. Res. Commun., 237, 313-317 (1997).
15. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., Peacocke, M., and Campisi, J., A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A., 92, 9363-9367 (1995).
16. Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y. Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Jr., Wrana, J. L., and Falb, D., The MAD-related protein Smad7 associates with the TGF-b receptor and functions as an antagonist of TGF-b signaling. Cell, 89, 1165-1173 (1997).
17. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., and Miyazono, K., Smad6 inhibits signalling by the TGF-b superfamily. Nature, 389, 622-626 (1997).
18. Ershler, W. B., and Keller, E. T., Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med., 51, 245-270 (2000).
19. Giuliani, N., Sansoni, P., Girasole, G., Vescovini, R., Passeri, G., Passeri, M., and Pedrazzoni, M., Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age-and menopause-related changes. Exp. Gerontol., 36, 547-557 (2001).
20. Ogura, N., Matsuda, U., Tanaka, F., Shibata, Y., Takiguchi, H., and Abiko, Y., In vitro senescence enhances IL-6 production in human gingival fibroblasts induced by lipopolysaccharide from Campylobacter rectus. Mech. Ageing Dev., 87, 47-59 (1996).
21. Tha, K. K., Okuma, Y., Miyazaki, H., Murayama, T., Uehara, T., Hatakeyama, R., Hayashi, Y., and Nomura, Y., Changes in expressions of proinflammatory cytokines IL-1 b, TNF-a and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res., 885, 25-31 (2000).
22. Spiotto, M. T., and Chung, T. D., STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate, 42, 88-98 (2000).
23. Hirano, T., Ishihara, K., and Hibi, M., Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene, 19, 2548-2556 (2000).